Company HLB SCIENCE Inc.

Equities

A343090

KR7343090007

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 03:30:00 14/05/2024 am IST			5-day change	1st Jan Change
2,955 ^KRW	0.00%		-0.34%	+15.43%

2023	HLB SCIENCE Inc. announced that it has received KRW 6.000000045 billion in funding from HLB Life Science Co., Ltd.	CI
2023	HLB SCIENCE Inc. announced that it expects to receive KRW 6.000000045 billion in funding from HLB Life Science Co., Ltd.	CI

HLB Science Inc, formerly DanDi Bioscience Inc, is a Korea-based company principally engaged in the research and development of biological pharmaceuticals. The Company is engaged in the research and development of sepsis treatment, antibiotics for super bacteria, dementia treatment, dementia diagnostic kits and other medicines products.

Managers	Title	Age	Since
Young-Min Park CEO	Chief Executive Officer	63	-

Members of the board	Title	Age	Since
Young-Min Park CEO	Chief Executive Officer	63	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	16,440,407	4,854,227 ( 29.53 %)	0	29.53 %

Name	Equities	%	Valuation
HLB GLOBAL CO., LTD. 35.93 %	5,906,928	35.93 %	15 M ₩
HLB LIFE SCIENCE CO., LTD. 20.47 %	3,365,165	20.47 %	8 M ₩
HLB BIOSTEP CO.,LTD. 7.934 %	1,304,348	7.934 %	3 M ₩

Name	Equities	%	Valuation
GL PHARM TECH CORP. 26.27%	20,147,479	26.27%	18,892,291 $

HLB Science, Inc.

Unit 304, 120, Neungdong-ro Gwangjin-gu

05029, Seoul

http://www.dandibio.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
HLB SCIENCE INC.	+15.43%	3.55Cr
VERTEX PHARMACEUTICALS INCORPORATED	+7.42%	11TCr
REGENERON PHARMACEUTICALS, INC.	+11.30%	11TCr
BIONTECH SE	-12.72%	2.22TCr
ARGENX SE	+0.44%	2.13TCr
GENMAB A/S	-4.18%	1.9TCr
WUXI APPTEC CO., LTD.	-37.85%	1.85TCr
BEIGENE, LTD.	-8.80%	1.68TCr
SAREPTA THERAPEUTICS, INC.	+37.21%	1.25TCr
LEGEND BIOTECH CORPORATION	-24.03%	808.97Cr

Bio Therapeutic Drugs